Indication
Primary Ciliary Dyskinesia
4 clinical trials
4 products
1 drug
Product
Sano Genetics Testing KitClinical trial
DNAI1 Primary Ciliary Dyskinesia: Genetic Testing, Patient Finding and Increasing Disease Awareness ProgramStatus: Recruiting, Estimated PCD: 2025-10-01
Product
RCT1100Clinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study, in Healthy Adult Participants and Open-Label Single Ascending Dose Study in Adults With Primary Ciliary Dyskinesia Caused by Pathogenic Mutations in the DNAI1 Gene to Evaluate the Safety and Tolerability of RCT1100Status: Recruiting, Estimated PCD: 2024-09-21
Clinical trial
Evaluating Bronchodilator Response in Patients With BronchiectasisStatus: Recruiting, Estimated PCD: 2024-04-01
Product
SalbutamolDrug
placeboClinical trial
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to PhenotypeStatus: Recruiting, Estimated PCD: 2024-04-30
Product
Albuterol